Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016)
Prothena Corp Public (PRTA) recorded quarterly Interest & Investment Income of $277000.0 in Q1 2016, up 246.25% quarter-over-quarter from $80000.0 in Q4 2015, and up 965.38% on a YoY basis from $26000.0 in Q2 2015.
Prothena Corp Public (PRTA) Interest & Investment Income (2012 - 2016) Analysis & Trends
Prothena Corp Public's Interest & Investment Income history runs 5 years deep, the most recent figure standing at $277000.0 for Q1 2016.
- In Q1 2016, Interest & Investment Income rose 965.38% year-over-year to $277000.0; the TTM figure through Mar 2016 stood at $447000.0 (up 419.77% YoY), while the FY2015 annual figure was $196000.0, up 148.1% from the prior year.
- Interest & Investment Income was $277000.0 for Q1 2016 at Prothena Corp Public, up from $80000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $277000.0 in Q1 2016 to a low of $5000.0 in Q4 2012.
- Historically, Interest & Investment Income has averaged $44857.1 across 5 years, with a median of $21500.0 in 2013.
- The sharpest annual moves came in 2014 and 2016: Interest & Investment Income declined 13.64% in 2014, then jumped 965.38% in 2016.
- A 5-year view of Interest & Investment Income shows it stood at $5000.0 in 2012, then jumped by 320.0% to $21000.0 in 2013, then climbed by 19.05% to $25000.0 in 2014, then surged by 220.0% to $80000.0 in 2015, then surged by 246.25% to $277000.0 in 2016.
- The last three Interest & Investment Income figures came in at $277000.0 (Q1 2016), $80000.0 (Q4 2015), and $50000.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Prothena Corp Public | 479.08 Mn | 149.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 277,000.00 |
| Dec 31, 2015 | 80,000.00 |
| Sep 30, 2015 | 50,000.00 |
| Jun 30, 2015 | 40,000.00 |
| Mar 31, 2015 | 26,000.00 |
| Dec 31, 2014 | 25,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Jun 30, 2014 | 16,000.00 |
| Mar 31, 2014 | 19,000.00 |
| Dec 31, 2013 | 21,000.00 |
| Sep 30, 2013 | 14,000.00 |
| Jun 30, 2013 | 14,000.00 |
| Mar 31, 2013 | 22,000.00 |
| Dec 31, 2012 | 5,000.00 |